DVA · News · 20260805N

Market Demand Trends

DAVITA INC. · 2026-08-05 · Importance 20 · Surprise 24

DaVita reported accelerating U.S. dialysis treatment-volume growth in the second quarter, supported by improved patient mortality and better phosphate-level management. The company’s patient-volume performance was stronger than expected and management described clinical-led volume growth as a key operating driver. Demand was partly offset by lower revenue per treatment as commercial enrollment declined and the payer mix shifted toward government coverage.

Key facts

• DaVita reported accelerating treatment-volume growth and lower mortality among patients in Q2 2026. source